Our Services
Curavit delivers a complete suite of CRO services, purpose-built for decentralized clinical trials. From study design and regulatory, through patient enrollment and engagement, to submission, Curavit delivers successful DCTs. Curavits services are designed to be unbundled and tailored to work with your team and your otherr partners.
Learn More01. Study Design
Curavit works with world-class principal investigators to identify endpoints and create protocols from “first principles” to design studies that are digitally native.
Learn More02. IRB Review
Curavit will manage your Institutional Review Board (IRB) process. We can work with your existing IRB or recommend an IRB for your study.
Learn More03. Patient Recruitment
Curavit recruits participants from the 97% of potential patients who are traditionally excluded from clinical research, including ethnically, and socio-economically underserved and underrepresented populations.
Learn More04. Consent & Enrollment
Curavit screens, consents, enrolls, and engages participants through Stratus, our proprietarty DCT platform.
Learn More05. Direct-to-Patient Logistics
Curavit coordinates all of the complex logistics - digital and physical - required to run a fully decentralized trial.
Learn More07. Lab Coordination
Curavit facilitates and manages participants' external labs and integrates the results into Stratus, our proprietary DCT platform.
Learn More08. Clinical Oversight
Curavit clinical study teams monitor trial data in real time to ensure patient safety, protocol adherence, and patient retention. This incorporates digital consent, telehealth, and remote data capture technologies.
Learn More09. Data & Intelligence
Curavit's data management team creates the statistical plan and provides full data analysis for the final study report.
Learn More10. Regulatory
Curavit's regulatory affairs scientists oversee the process of getting your therapy or device throuigh FDA review and approval and onto the market.
Learn More
Our Services
Curavit delivers a complete suite of CRO services, purpose-built for decentralized clinical trials. From study design and regulatory, through patient enrollment and engagement, to submission, Curavit delivers successful DCTs. Curavits services are designed to be unbundled and tailored to work with your team and your otherr partners.
Learn MoreUpcoming Events
Curavit in the News
Industry Predictions For 2023
Top industry experts weigh in on what the new year holds for the pharma industry.
PREDICTION #1: In 2023, the chasm will widen between those companies investing in analytics-based, digital-first commercial models and those still sitting on the fence and taking a measured approach.
Life sciences companies are notoriously cautious. However, COVID-19 put many companies in the uncomfortable position of forcing new ways of working, engaging with customers, and new technologies. For many companies, the changes are sticking, ushering in the digital-first era.
We have started seeing the impact of the adoption of new technologies, such as platform intelligence solutions, ‘on the ground.’ In fact, 89% of companies surveyed by DHC Group reported that they are successfully executing an AI-driven omnichannel strategy across sales and marketing and scaling up.1
Contact Curavit
Let’s Talk
